Gabelli Funds
DMII icon

Gabelli Funds’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Gabelli Funds’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
133,000
-28,400
-18% -$285K 0.01% 852
2026
Q1 		$1.61M Buy
+161,400
New +$1.61M 0.01% 801

Other funds holding DMII

Karpus Investment Management
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Gabelli Funds's DMII Position: Q2 2026 in Review

Gabelli Funds reduced its Drugs Made In America Acquisition II Corp (DMII) stake by 18% in Q2 2026, selling an estimated $285K and leaving 133,000 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #852.

Gabelli Funds first reported a position in DMII in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.61M in Q1 2026. 69 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • Gabelli Funds held 133,000 shares of Drugs Made In America Acquisition II Corp worth $1.34M as of Q2 2026.
  • Gabelli Funds sold 28,400 Drugs Made In America Acquisition II Corp shares in Q2 2026, an estimated $285K.
  • Drugs Made In America Acquisition II Corp made up 0.01% of Gabelli Funds's portfolio in Q2 2026, its #852 holding.
  • Gabelli Funds first reported a position in Drugs Made In America Acquisition II Corp in Q1 2026 and has held it in 2 quarters since.
  • Gabelli Funds's Drugs Made In America Acquisition II Corp position peaked at $1.61M in Q1 2026.
  • 69 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.